Novavax, Inc. - Company Profile and SWOT Analysis
Summary
Novavax, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novavax, Inc. (Novavax or 'the company') is a biotechnology company that discovers, develops and markets vaccines for the prevention of serious infectious diseases. The company's major offerings include various vaccine candidates against respiratory syncytial virus (RSV), seasonal influenza, R21 and the Ebola virus. Novavax markets vaccine candidates under Novavax, ResVax, Resolve, Prepare, Matrix, and Nuvaxovid brand names. It uses innovative proprietary recombinant nanoparticle vaccine technologies to develop various vaccines related to emerging disease threats. The company also develops various adjuvant formulations through Matrix-M technology. It operates manufacturing facilities in Gaithersburg, Maryland, and Uppsala, Sweden. The company is headquartered in Gaithersburg, Maryland, the US.
Scope
- Detailed information on Novavax, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
- Intelligence on Novavax, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novavax, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Novavax, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novavax, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novavax, Inc.'s business structure, strategy and prospects.
- Company Snapshot
- Novavax, Inc.: Company Overview
- Novavax, Inc.: Overview and Key Facts
- Novavax, Inc.: Overview
- Novavax, Inc.: Key Facts
- Novavax, Inc.: Key Employees
- Novavax, Inc.: Key Employee Biographies
- Novavax, Inc.: Major Products and Services
- Novavax, Inc.: Management Statement
- Novavax, Inc.: Locations and Subsidiaries
- Novavax, Inc.: Key Competitors
- Novavax, Inc.: Company Analysis
- Novavax, Inc.: Business Description
- Novavax, Inc.: SWOT Analysis
- Novavax, Inc.: SWOT Overview
- Novavax, Inc.: Strengths
- Novavax, Inc.: Weaknesses
- Novavax, Inc.: Opportunities
- Novavax, Inc.: Threats
- Novavax, Inc.: Corporate Financial Deals Activity
- Novavax, Inc.: Financial Deals Overview
- Novavax, Inc.: Targets and Partners
- Novavax, Inc.: Top Deals 2021 - 2025YTD*
- Novavax, Inc.: Advisors
- Novavax, Inc.: Top Legal Advisors
- Novavax, Inc.: Top Financial Advisors
- Novavax, Inc.: Capital Raising
- Novavax, Inc.: Partnership
- Novavax, Inc.: Divestments
- Novavax, Inc.: Private Equity and Ownership
- Novavax, Inc.: Recent Developments
- Novavax, Inc.: News and Events Summary
- Novavax, Inc.: Corporate Governance
- Novavax, Inc.: Financial Performance
- Novavax, Inc.: Regulatory and Legal Events
- Novavax, Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Novavax, Inc.: Key Facts
- Table 2: Novavax, Inc.: Key Employees
- Table 3: Novavax, Inc.: Locations and Subsidiaries
- Table 4: Novavax, Inc.: Key Competitors
- Table 5: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Table 7: Novavax, Inc.: Targets and Partners
- Table 8: Novavax, Inc.: Top Deals 2021 - 2025YTD*
- Table 9: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 10: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 11: Novavax, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
- Table 12: Novavax, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
- Table 13: Novavax, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
- Table 14: Novavax, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
- Table 15: Novavax, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
- Table 16: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2021 - YTD*2025)
- Table 17: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2021 - YTD*2025)
- Table 18: Novavax, Inc.: News and Events Summary
- Table 19: Novavax, Inc.: Corporate Governance
- Table 20: Novavax, Inc.: Financial Performance
- Table 21: Novavax, Inc.: Regulatory and Legal Events
- Table 22: Novavax, Inc.: Research & Development
- List of Figures
- Figure 1: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Novavax, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Figure 3: Novavax, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
- Figure 4: Novavax, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
- Figure 5: Novavax, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
- Figure 6: Novavax, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
- Figure 7: Novavax, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
- Figure 8: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2021 - YTD*2025)
- Figure 9: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2021 - YTD*2025)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook